TAG:
Esoteric testing
Esoteric testing allows the analysis of rare substances or molecules that are not performed in a routine clinical lab. Many large commercial lab companies outsource complex tests to reference and esoteric testing labs. However, as technology continues to expand laboratory testing, tests that are considered esoteric today may become routine in just a few years. This is often the result of work performed by dedicated research and development scientists.
These tests are ordered when a physician requires additional detailed information, outside routine lab testing, to complete a diagnosis, establish a prognosis or choose and monitor a therapeutic regimen. Esoteric testing generally requires sophisticated instruments and materials as well as specialized personnel to perform and analyze results. The tests are typically outsourced to independent, specialized clinical reference laboratories because it is not cost effective for hospitals and physician office laboratories to perform the tests in-house.
These tests are ordered less frequently than routine tests and are generally priced higher than the routine tests. Esoteric testing is typically related to the medical fields such as endocrinology, genetics, immunology, microbiology, molecular diagnostics, oncology, serology and toxicology. Molecular diagnostics is the fastest growing segment of esoteric clinical testing.
The American Chemical Society publishes the Directory of Rare Analyses (DORA) which catalogues rarely ordered clinical tests and provides details on the labs performing them.
The challenges for labs performing such tests include not only finding qualified medical technologists, but also paying them the higher salaries they command because of the scarcity of their skill sets. In addition, materials used in these tests can also be costly, particularly because they are not usually purchased in large enough quantities to qualify for economies of scale.
Labs that perform these tests have capabilities including:
• Allergy
• Complex anatomic pathology with board-certified pathologist
• Bone markers
• Genetic analysis
• HLA testing
• Functional assays of the immune system
• Toxicology
In the U.S., labs that perform these tests range from ARUP Laboratories, Mayo Medical Laboratories, Quest Diagnostics Incorporated, and Laboratory Corporation of America to a growing number of specialty esoteric testing laboratories that offer proprietary esoteric assays. Examples of such specialty testing lab companies include Myriad Genetics, Genomic Health, and Foundation Medicine.
Bi-Coastal Powerhouse Formed by Lab Merger
By Robert Michel | From the Volume VI No. 13 – September 20, 1999 Issue
CEO SUMMARY: Changes to healthcare continue to stimulate responses from independent commercial laboratories. This time it’s a merger of Las Vegas-based Associated Pathologists Laboratories with American Medical Laboratories of Chantilly, Virginia. This combination creates the third-larg…
Reference Labs Intensify Battle for Send-Out Tests
By Robert Michel | From the Volume VI No. 12 – August 30, 1999 Issue
CEO SUMMARY: Expect a battle royale for hospital reference and esoteric testing by the handful of labs that offer such testing to hospitals throughout the country. With the merger of Quest Diagnostics Incorporated and SmithKline Beecham Clinical Laboratories now a fact, competitors are al…
Ten Myths of Lab Management That Led the Clinical Lab Industry Astray
By Robert Michel | From the Volume VI No. 11 – August 9, 1999 Issue
Part One of a Special Series CEO SUMMARY: One of our most popular series ever was the “13 Perilous Parallels” of laboratory management. This four-part story appeared in 1996 and chronicled similar management strategies used by various national laboratories during the…
Veterans Administration Network Restructures Using Partnering, Telepathology
By Robert Michel | From the Volume V No. 12 – September 8, 1998 Issue
CEO SUMMARY: Economic pressures are forcing even the traditional and staid Veterans Administration to extensively reconfigure its laboratory services. At this year’s Executive War College in New Orleans, participants learned how one eight-hospi…
Nichols Institute Earns ISO 9001 Certification
By Robert Michel | From the Volume V No. 9 – July 6, 1998 Issue
CEO SUMMARY: Although it’s the first ISO 9001-certified clinical laboratory in North America, Quest Diagnostics’ Nichols Institute is a late-comer to the party. Most major diagnostics companies already have ISO 9001 certification. This issue of THE DARK REPORT explores why Nichols’ …
Niche Markets Boost Earnings For Both DIANON And LabOne
By Robert Michel | From the Volume IV No. 16 – November 17, 1997 Issue
THIRD QUARTER EARNINGS at DIANON Systems and LabOne, Inc. demonstrate that niche market strategies can be growth engines for clinical laboratories, even in the face of declining reimbursement. As the crunch in clinical testing hit the laboratory industry in recent y…
LabCorp Hosts DARK REPORT For Burlington Site Visit
By Robert Michel | From the Volume IV No. 13 – September 15, 1997 Issue
CEO SUMMARY: During the years of sustained bad financial news that dogged the major laboratories, there was a reluctance to speak publicly about any aspect of the laboratory business. That era seems to be ending, as LabCorp and the other national laboratories become friendlier and more ac…
Tennessee Lab Network To Become Operational
By Robert Michel | From the Volume IV No. 12 – August 25, 1997 Issue
CEO SUMMARY: Although news of regional laboratory networks disappeared from the pages of lab industry publications, the movement is far from dead. In Tennessee, 13 hospital laboratories are about to launch the Middle Tennessee Healthcare Network. Organizers believe they have solutions to …
Las Vegas Lab Gathering Debates Industry Trends
By Robert Michel | From the Volume IV No. 4 – March 10, 1997 Issue
CEO SUMMARY: Always a good forum for discussion of laboratory industry trends, this year’s meeting in Las Vegas addressed government regulation, laboratory automation and everything in between. Here is a brief rundown on some of the more interesting insights and observations….
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized